全文获取类型
收费全文 | 69467篇 |
免费 | 4599篇 |
国内免费 | 1650篇 |
专业分类
耳鼻咽喉 | 630篇 |
儿科学 | 1255篇 |
妇产科学 | 896篇 |
基础医学 | 5806篇 |
口腔科学 | 1660篇 |
临床医学 | 6774篇 |
内科学 | 7600篇 |
皮肤病学 | 619篇 |
神经病学 | 3966篇 |
特种医学 | 1572篇 |
外国民族医学 | 6篇 |
外科学 | 6506篇 |
综合类 | 12147篇 |
现状与发展 | 1篇 |
一般理论 | 4篇 |
预防医学 | 8987篇 |
眼科学 | 1094篇 |
药学 | 5555篇 |
125篇 | |
中国医学 | 8460篇 |
肿瘤学 | 2053篇 |
出版年
2024年 | 149篇 |
2023年 | 1060篇 |
2022年 | 1728篇 |
2021年 | 2752篇 |
2020年 | 2477篇 |
2019年 | 4571篇 |
2018年 | 2907篇 |
2017年 | 2719篇 |
2016年 | 2068篇 |
2015年 | 1753篇 |
2014年 | 4226篇 |
2013年 | 3835篇 |
2012年 | 3857篇 |
2011年 | 4763篇 |
2010年 | 4241篇 |
2009年 | 3162篇 |
2008年 | 2990篇 |
2007年 | 3148篇 |
2006年 | 2872篇 |
2005年 | 2377篇 |
2004年 | 1933篇 |
2003年 | 1788篇 |
2002年 | 1212篇 |
2001年 | 1093篇 |
2000年 | 884篇 |
1999年 | 807篇 |
1998年 | 636篇 |
1997年 | 575篇 |
1996年 | 489篇 |
1995年 | 529篇 |
1994年 | 516篇 |
1993年 | 373篇 |
1992年 | 366篇 |
1991年 | 361篇 |
1990年 | 288篇 |
1989年 | 280篇 |
1988年 | 289篇 |
1987年 | 242篇 |
1986年 | 223篇 |
1985年 | 607篇 |
1984年 | 618篇 |
1983年 | 472篇 |
1982年 | 527篇 |
1981年 | 551篇 |
1980年 | 483篇 |
1979年 | 458篇 |
1978年 | 360篇 |
1977年 | 333篇 |
1976年 | 236篇 |
1975年 | 155篇 |
排序方式: 共有10000条查询结果,搜索用时 17 毫秒
51.
52.
Jin Wu Hao Wang Qing Li Qian-Ying Guo Si-Qi Tao Yu-Xian Shen Zheng-Sheng Wu 《Pathology, research and practice》2019,215(9):152523
Mammary carcinoma (MC) is one of most common malignancy in women, and ring finger protein 2 (RNF2) possesses various roles in vast human tumors. In MC tissues as well as in cell lines RNF2 exhibited high expression, had significant association with tumor size, lymph node status, TNM stage, patients’ poor survival, and promoted cell proliferation, colony formation, cell migration and invasion of MC cell lines which was mediated by downregulation of E-cadherin protein. These data reveal that RNF2 protein plays a vital role in the development of MC and may be a potential therapy target of MC. 相似文献
53.
Jae Hwang Song Chan Kang Deuk Soo Hwang Dong Hun Kang Yong Hwan Kim 《Foot and Ankle Surgery》2019,25(6):748-754
BackgroundThe purpose of this study was to investigate and compare the clinical outcomes of dorsal suspension with those of neurectomy for the treatment of Morton’s neuroma.MethodsWe conducted a retrospective study of dorsal suspension and neurectomy group. The dorsal suspension was performed by dorsal transposition of neuroma over the dorsal transverse ligament after neurolysis. The visual analog scale (VAS), the Foot and Ankle Ability Measure (FAAM), postoperative satisfaction, and complications were evaluated.ResultsBoth groups reported significant pain relief, and there were no significant differences between the groups with respect to postoperative pain. The postoperative FAAM outcomes showed no significant between-group differences. Satisfaction analysis showed ‘excellent’ and ‘good’ results in the dorsal suspension and neurectomy groups (95% and 77.7%, respectively). Complications of numbness and paresthesia reported in the dorsal suspension group (5% and 5%, respectively) were significantly fewer than those of neurectomy group (61.1% and 33.3%, respectively) (both, p < .05).ConclusionsWith its favorable results, dorsal suspension can be another operative option for the treatment of Morton’s neuroma.Level of Evidence: Level III, retrospective comparative case series. 相似文献
54.
55.
56.
57.
K. Miura S. Yamaoka K. Arizono S. Ohba T. Koga T. Kawasaki N. Yoshida I. Asahina 《The British journal of oral & maxillofacial surgery》2019,57(6):529-535
Our aim was to evaluate the long-term skeletal stability of the mandible in 21 patients after orthognathic surgery with physiological positioning. The measurement points SNB, B point (X, Y), Pog (X, Y), and the angle of the ramus were measured on cephalometric photographs to assess skeletal stability preoperatively, immediately after operation, and one and two years postoperatively. In addition, we evaluated the clinical symptoms of disorders of the temporomandibular joint (TMJ). The analysis of the cephalometric photographs showed that SNB, B point X, and Pog X showed no significant differences among the postoperative time points. On the other hand, B point Y and Pog Y showed no significant differences throughout the study period. We compared the angle of the ramus before operation and two years postoperatively, and no significant difference was found. In addition, no cases showed any pathological symptoms of disorders of the TMJ two years postoperatively. The long-term stability after orthognathic surgery with physiological positioning was confirmed, and it seems to be a reliable orthognathic treatment in patients with mandibular prognathism. 相似文献
58.
Katherine M. Duszynski Nicole L. Pratt John W. Lynch Jesia G. Berry Michael S. Gold 《Vaccine》2019,37(2):280-288
Objective
To determine whether differences in combination DTaP vaccine types at 2, 4 and 6?months of age were associated with mortality (all-cause or non-specific), within 30?days of vaccination.Design
Observational nationwide cohort study.Setting
Linked population data from the Australian Childhood Immunisation Register and National Death Index.Participants
Australian infants administered a combination trivalent, quadrivalent or hexavalent DTaP vaccine (DTaP types) between January 1999 and December 2010 at 2, 4 and 6?months as part of the primary vaccination series. The study population included 2.9, 2.6, & 2.3?million children in the 2, 4 and 6?month vaccine cohorts, respectively.Main outcome measures
Infants were evaluated for the primary outcome of all-cause mortality within 30?days. A secondary outcome was non-specific mortality (unknown cause of death) within 30?days of vaccination. Non-specific mortality was defined as underlying or other cause of death codes, R95 ‘Sudden infant death syndrome’, R96 ‘Other sudden death, cause unknown’, R98 ‘Unattended death’, R99 ‘Other ill-defined and unspecified cause of mortality’ or where no cause of death was recorded.Results
The rate of 30?day all-cause mortality was low and declined from 127.4 to 59.3 deaths per 100,000 person-years between 2 and 6?month cohorts. When compared with trivalent DTaP vaccines, no elevated risk in all-cause or non-specific mortality was seen with any quadrivalent or hexavalent DTaP vaccines, for any cohort.Conclusion
Use of routine DTaP combination vaccines with differing disease antigens administered during the first six months of life is not associated with infant mortality. 相似文献59.
60.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493